Business Wire

PhocusWright Conference Honors Magicstay.Com With Launch People's Choice Award

26.11.2019 16:28:00 EET | Business Wire | Press release

Share

On Thursday, November 21, MagicStay won the Launch People's Choice Award at the Phocuswright Conference in Fort Lauderdale, Florida - the world's leading event showcasing the latest technological trends in tourism.
This prestigious award, a veritable acknowledgement of the entire tourism and mobility sector, is a reflection of MagicStay's development strategy, which was put into effect over the past two years on a global scale. With this award, MagicStay has established itself as a key player in Business Travel and mobility on the international stage.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191126005486/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

A special prize for a special team! #MagicTeam (Photo: Business Wire)

MagicStay, winner of the Launch People's Choice Award

The Launch People's Choice Award recognizes companies which are at least 4 years old and have come up with an innovation that revolutionizes the travel industry. Through this award, the Phocuswright Conference showcases the latest trends and technological innovations in the main sectors of the travel market every year.

In a 10-minute pitch, William Lecerf, co-founder of MagicStay, was able to impress the Dragons - the ten members of the Jury. He received nine positive endorsements in front of around 2,000 of the most influential international experts from the travel industry. The prize was presented to William Lecerf, co-founder (on the left), Valéry Linyer, co-founder and CEO (in the center) and Slobodan Petrovic, COO (on the right).

These 2,000 experts then elected MagicStay.com ahead of twelve competitors previously selected by Phocuswright: Affirm, Airdna, Amadeus, Arrivalist, Cover Genius, HotelRunner, Left Travel, Mistifly, Nezasa, Sift, Kiwi or Travelcompsitor. The prize was awarded jointly to MagicStay.com and Kiwi.

The Dragons' comments were very complimentary:
"You are building a database which offers unique value that no-one else has managed to develop".
Will Philippson, former Co-founder and COO SilveRail Technologies

"I really like the fact that your content is available in the SBTs".
Charuta Fadnis, Senior Director Product Strategy and Analytics BCD Travel

"As an expat looking for accommodation in a foreign country, anything you can do to simplify this process is absolutely fantastic. It's an infernal procedure that companies spend a lot of time dealing with and your solution is BRILLANT".
Philip Wolf, Serial Board Director and Founder Phocuswright Inc.

"I was really impressed by your Duty of Care presentation. As a large company, I know that this issue is one of the biggest fears we have to face when sending our employees abroad on assignments".
Gayle Knolls, Head of Business Development TRAVELPORT

An effective development strategy

Launched in 2013 in Grasse, the www.MagicStay.com platform devoted its first five years of business to R&D.
After initially focusing on the market of trade show organizers, since 2016 MagicStay has been offering business travelers and, since the beginning of this year, expatriates and/or persons on professional mobility assignments, a secure alternative to professional hotels by responding to duty of care challenges, traveler safety demands and personal data protection, required by large companies.
While broadening its scope, the hosting platform dedicated to professionals has doubled its offer since the beginning of the year. It now has more than 600,000 apartments, villas or apart-hotels available throughout the world (in more than 3,000 cities and 130 countries).
In 2020, MagicStay hopes to reach one million hosting units.

The photo on the previous page and other photos are available on request

www.magicstay.com

MagicStay media library (press releases, logo, photo gallery, etc.)

Join us on: Facebook Twitter LinkedIn

The original source-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the source-language text, which is the only version of the text intended to have legal effect.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

MagicStay press contacts:
Fabienne Frédal (AB3C)
Tel. +33 (0)1 53 30 74 07 - fabienne@ab3c.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 15:00:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.

Fortegra Completes Acquisition by DB Insurance29.5.2026 23:30:00 EEST | Press release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 23:01:00 EEST | Press release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye